home / stock / cris / cris quote
Last: | $6.38 |
---|---|
Change Percent: | 2.08% |
Open: | $6.29 |
Close: | $6.25 |
High: | $6.63 |
Low: | $6.28 |
Volume: | 20,375 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.38 | $6.29 | $6.25 | $6.63 | $6.28 | 20,375 | 07-03-2024 |
$6.25 | $6.38 | $6.25 | $6.77 | $6.0679 | 33,106 | 07-02-2024 |
$6.38 | $7 | $6.38 | $7.085 | $6.37 | 23,006 | 07-01-2024 |
$6.9 | $7.5 | $6.9 | $7.5 | $6.63 | 84,425 | 06-28-2024 |
$7.45 | $7.51 | $7.45 | $7.7292 | $7.19 | 26,371 | 06-27-2024 |
$7.5 | $7.78 | $7.5 | $8 | $7.5 | 15,935 | 06-26-2024 |
$7.84 | $8.22 | $7.84 | $8.29 | $7.84 | 17,532 | 06-25-2024 |
$8.2 | $7.81 | $8.2 | $8.42 | $7.77 | 36,319 | 06-24-2024 |
$7.96 | $7.96 | $7.96 | $8.02 | $7.7 | 31,167 | 06-21-2024 |
$7.96 | $7.75 | $7.96 | $7.96 | $7.5701 | 27,587 | 06-20-2024 |
$7.8 | $8.28 | $7.8 | $8.48 | $7.8 | 41,185 | 06-19-2024 |
$7.8 | $8.28 | $7.8 | $8.48 | $7.8 | 41,185 | 06-18-2024 |
$8.22 | $8.23 | $8.22 | $8.4721 | $8.0201 | 25,040 | 06-17-2024 |
$8.13 | $8.54 | $8.13 | $8.5908 | $7.9 | 24,862 | 06-14-2024 |
$8.5 | $8.8 | $8.5 | $8.83 | $8.49 | 13,910 | 06-13-2024 |
$8.8 | $8.52 | $8.8 | $9.02 | $8.47 | 10,124 | 06-12-2024 |
$8.59 | $8 | $8.59 | $8.59 | $7.77 | 36,539 | 06-11-2024 |
$8 | $8.84 | $8 | $8.84 | $6.32 | 232,348 | 06-10-2024 |
$8.84 | $9.66 | $8.84 | $9.66 | $8.84 | 28,133 | 06-07-2024 |
$9.67 | $9.55 | $9.67 | $9.7237 | $9.41 | 10,601 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-05-25 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire Data update expands AML dataset from 5 to 30 patients LEXINGTON, Mass. , May 14, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of...
Curis to Present Updated Data from the TakeAim Leukemia Study PR Newswire LEXINGTON, Mass. , May 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule ...